# OnCo record paper-interfant-06-pieters-jco-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-interfant-06-pieters-jco-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-interfant-06-pieters-jco-2019" ;
  schema:name "Interfant-06: outcome of infants under one year with acute lymphoblastic leukaemia"@en ;
  schema:description "This international trial of infant leukaemia found no benefit from adding myeloid-style chemotherapy courses, and confirmed that KMT2A-rearranged infants remain a high-risk group with survival under 50 percent, setting the baseline that blinatumomab has since improved."@en ;
  schema:url <https://onco.cc/key-papers/paper-interfant-06-pieters-jco-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.19.00261>, <https://pubmed.ncbi.nlm.nih.gov/31283407/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.19.00261> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Pieters R, De Lorenzo P, Ancliffe P, et al." ;
  onco:cancers <https://onco.cc/cancers/all-infant/> ;
  onco:trials <https://onco.cc/trials/interfant-06/> ;
  onco:journals <https://onco.cc/journals/jco/> .